A phase II clinical trial has found dimethyltryptamine (DMT), one of the psychoactive components traditionally used in the Amazonian psychedelic ritual ayahuasca, might be a promising therapy for depression.
The psychedelic pharmaceutical company…
Continue Reading
News Source: www.theguardian.com

Leave a Reply